• Explore /
  • Poster
  • / Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO.

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO.

Abstract Poster

Authors

Ralf Hofheinz

Ralf Hofheinz

University Medical Center Mannheim, Mannheim, Germany

Ralf Hofheinz , Gerrit zur Hausen , Kersten Borchert , Albrecht Kretzschmar , Matthias Philip Ebert , Thomas Jens Ettrich , Michael Koenigsmann , Georg Martin Haag , Volker A. Hagen , Thomas Hoehler , Nils Homann , Hendrik Kroening , Peter Reichardt , Michael Rieger , Christian Teschendorf , Eray Goekkurt , Udo Lindig , Wolff H. Schmiegel , Claudia Pauligk , Salah-Eddin Al-Batran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02581462

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS4133)

DOI

10.1200/JCO.2017.35.15_suppl.TPS4133

Abstract #

TPS4133

Poster Bd #

124a

Abstract Disclosures

Similar Posters

First Author: Ralf Hofheinz

First Author: Salah-Eddin Al-Batran

First Author: Hongli Li

First Author: Tomono Kawase